(3r)-((2,3-dihydro-5-methyl-3-((4-morpholinyl)methyl)pyrrolo-(1,2,3-de)-1,4-benzoxazin-6-yl)(1-naphthalenyl))methanone and noladin ether

(3r)-((2,3-dihydro-5-methyl-3-((4-morpholinyl)methyl)pyrrolo-(1,2,3-de)-1,4-benzoxazin-6-yl)(1-naphthalenyl))methanone has been researched along with noladin ether in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (33.33)	29.6817
2010's	2 (66.67)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Fowler, CJ; Lambert, DM	1
Aiello, F; Biotti, I; Brizzi, A; Brizzi, V; Cascio, MG; Corelli, F; Di Marzo, V; Frosini, M; Ligresti, A; Pertwee, RG	1
Buzard, DJ; Han, S; Jones, RM; Thatte, J	1

Reviews

2 review(s) available for (3r)-((2,3-dihydro-5-methyl-3-((4-morpholinyl)methyl)pyrrolo-(1,2,3-de)-1,4-benzoxazin-6-yl)(1-naphthalenyl))methanone and noladin ether

Article	Year
The endocannabinoid system: drug targets, lead compounds, and potential therapeutic applications. Journal of medicinal chemistry, 2005, Aug-11, Volume: 48, Issue:16 Topics: Amides; Amidohydrolases; Amines; Animals; Arachidonic Acids; Binding Sites; Cannabinoid Receptor Modulators; Drug Design; Endocannabinoids; Esters; Ethers; Glycerides; Humans; Ligands; Monoacylglycerol Lipases; Polyunsaturated Alkamides; Receptors, Cannabinoid	2005
Therapeutic utility of cannabinoid receptor type 2 (CB(2)) selective agonists. Journal of medicinal chemistry, 2013, Nov-14, Volume: 56, Issue:21 Topics: Animals; Drug Design; Humans; Ligands; Models, Molecular; Molecular Conformation; Receptor, Cannabinoid, CB2; Structure-Activity Relationship; Substrate Specificity	2013

Article

Year

The endocannabinoid system: drug targets, lead compounds, and potential therapeutic applications.

Journal of medicinal chemistry, 2005, Aug-11, Volume: 48, Issue:16

Topics: Amides; Amidohydrolases; Amines; Animals; Arachidonic Acids; Binding Sites; Cannabinoid Receptor Modulators; Drug Design; Endocannabinoids; Esters; Ethers; Glycerides; Humans; Ligands; Monoacylglycerol Lipases; Polyunsaturated Alkamides; Receptors, Cannabinoid

2005

Therapeutic utility of cannabinoid receptor type 2 (CB(2)) selective agonists.

Journal of medicinal chemistry, 2013, Nov-14, Volume: 56, Issue:21

Topics: Animals; Drug Design; Humans; Ligands; Models, Molecular; Molecular Conformation; Receptor, Cannabinoid, CB2; Structure-Activity Relationship; Substrate Specificity

2013

Other Studies

1 other study(ies) available for (3r)-((2,3-dihydro-5-methyl-3-((4-morpholinyl)methyl)pyrrolo-(1,2,3-de)-1,4-benzoxazin-6-yl)(1-naphthalenyl))methanone and noladin ether

Article	Year
Resorcinol-sn-glycerol derivatives: novel 2-arachidonoylglycerol mimetics endowed with high affinity and selectivity for cannabinoid type 1 receptor. Journal of medicinal chemistry, 2011, Dec-22, Volume: 54, Issue:24 Topics: Animals; Arachidonic Acids; Brain; CHO Cells; Cricetinae; Cricetulus; Cytochrome P-450 CYP3A; Endocannabinoids; Esterases; Esters; Ethers; Glycerides; HEK293 Cells; Humans; In Vitro Techniques; Mice; Molecular Mimicry; Monoglycerides; Phenols; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Resorcinols; Stereoisomerism; Structure-Activity Relationship	2011

Article

Year

Resorcinol-sn-glycerol derivatives: novel 2-arachidonoylglycerol mimetics endowed with high affinity and selectivity for cannabinoid type 1 receptor.

Journal of medicinal chemistry, 2011, Dec-22, Volume: 54, Issue:24

Topics: Animals; Arachidonic Acids; Brain; CHO Cells; Cricetinae; Cricetulus; Cytochrome P-450 CYP3A; Endocannabinoids; Esterases; Esters; Ethers; Glycerides; HEK293 Cells; Humans; In Vitro Techniques; Mice; Molecular Mimicry; Monoglycerides; Phenols; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Resorcinols; Stereoisomerism; Structure-Activity Relationship

2011